Outlet Granma reported that over 45 nations have requested Cuba for Interferon Alpha 2b Human Recombinant supplies given that this drug is effective in treating Covid-19 patients.
Interferon is produced by the Center for Genetic Engineering and Biotechnology (CIGB), a Cuban institution that enjoys prestige in the international scientific community. Created in the 1980s, this drug has been used in cases of acute respiratory conditions and viral infections such as hepatitis B and C, shingles, and HIV/AIDS.
Cuban Biotech to the Rescue: The Story of a Potential Anti-COVID-19 Drug Told By One of Its Creators